| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5546 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2870 | 2020 |
| Best practices in child and adolescent tuberculosis care WH Organization World Health Organization, 2018 | 1852 | 2018 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1743 | 2020 |
| COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study F Götzinger, B Santiago-García, A Noguera-Julián, M Lanaspa, ... The Lancet Child & Adolescent Health 4 (9), 653-661, 2020 | 1535 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1389 | 2021 |
| Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection S Feng, DJ Phillips, T White, H Sayal, PK Aley, S Bibi, C Dold, M Fuskova, ... Nature medicine 27 (11), 2032-2040, 2021 | 1116 | 2021 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 758 | 2021 |
| T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial KJ Ewer, JR Barrett, S Belij-Rammerstorfer, H Sharpe, R Makinson, ... Nature medicine 27 (2), 270-278, 2021 | 628 | 2021 |
| Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses JR Barrett, S Belij-Rammerstorfer, C Dold, KJ Ewer, PM Folegatti, ... Nature medicine 27 (2), 279-288, 2021 | 351 | 2021 |
| Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) A Flaxman, NG Marchevsky, D Jenkin, J Aboagye, PK Aley, B Angus, ... The Lancet 398 (10304), 981-990, 2021 | 281 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial J Frater, KJ Ewer, A Ogbe, M Pace, S Adele, E Adland, J Alagaratnam, ... The lancet HIV 8 (8), e474-e485, 2021 | 230 | 2021 |
| Oxford COVID Vaccine Trial Group Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... Lancet 397 (10269), 99-111, 2021 | 141 | 2021 |
| Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009–2012 S Bamrah, R Brostrom, F Dorina, L Setik, R Song, LM Kawamura, ... The International journal of tuberculosis and lung disease 18 (8), 912-918, 2014 | 138 | 2014 |
| AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific TH1 response with a diverse TCR repertoire PA Swanson, M Padilla, W Hoyland, K McGlinchey, PA Fields, S Bibi, ... Science translational medicine 13 (620), eabj7211, 2021 | 84 | 2021 |
| Efficacy of highly active antiretroviral therapy in HIV-1–Infected children in Kenya R Song, J Jelagat, D Dzombo, M Mwalimu, K Mandaliya, K Shikely, ... Pediatrics 120 (4), e856-e861, 2007 | 75 | 2007 |
| Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination K Hillson, SC Clemens, SA Madhi, M Voysey, AJ Pollard, AM Minassian The Lancet 398 (10312), 1683-1684, 2021 | 72 | 2021 |
| Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: a systematic review EL Sudbury, V Clifford, NL Messina, R Song, N Curtis Journal of Infection 81 (6), 873-881, 2020 | 64 | 2020 |
| Computer-aided reading of tuberculosis chest radiography: moving the research agenda forward to inform policy FA Khan, T Pande, B Tessema, R Song, A Benedetti, M Pai, K Lönnroth, ... European Respiratory Journal 50 (1), 2017 | 57 | 2017 |
| Technical expert group meeting report: commercial products for preserving clinical specimens for the diagnosis of tuberculosis WH Organization World Health Organization, 2017 | 55 | 2017 |
Merryn VoyseySenior Statistician, University of Oxford在 paediatrics.ox.ac.uk 的电子邮件经过验证
